Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIND-CKD: Ferric Carboxymaltose vs Oral Iron in NDD-CKD
NCT00994318Phase 3Completed
- Sponsor
- CSL Vifor
- Start
- Dec 2009
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by CSL Vifor. Started Dec 2009; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT00994318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00994318.